Streetbeat News

Analyst Ratings

HOOD

Robinhood Markets Inc (NASDAQ:HOOD) shares are trading higher after JMP Securities analyst Devin Ryan reiterated a Market Outperform rating and maintained a $25 price target. The stock has seen increased retail investor attention, being among the most mentioned on Reddit's r/wallstreetbets and Stocktwits. Robinhood is set to report Q2 financial results on Aug. 2, with an expected loss of 1 cent per share on quarterly revenue of $470.28 million.

Portfolio Pulse from Adam Eckert

July 11, 2023 | 1:12 pm

FMC

Morgan Stanley analyst Vincent Andrews has maintained an Overweight rating on FMC (NYSE:FMC) but lowered the price target from $145 to $110.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 1:12 pm

ETRN

Morgan Stanley analyst Devin McDermott has reiterated an Overweight rating on Equitrans Midstream (NYSE:ETRN) and maintained a $14 price target.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 1:11 pm

XPEV

Goldman Sachs analyst Tina Hou has initiated coverage on XPeng (NYSE:XPEV) with a Buy rating.

Portfolio Pulse from richadhand@benzinga.com

July 11, 2023 | 1:10 pm

EQH

Morgan Stanley analyst Nigel Dally has reiterated an Overweight rating on Equitable Hldgs (NYSE:EQH) and maintained a $40 price target.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 1:09 pm

ENLC

Morgan Stanley analyst Robert Kad has reiterated an Overweight rating on EnLink Midstream (NYSE:ENLC) and maintained a $17 price target.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 1:08 pm

USCB

Janney Montgomery Scott analyst Feddie Strickland has initiated coverage on USCB Financial Holdings with a Neutral rating.

Portfolio Pulse from richadhand@benzinga.com

July 11, 2023 | 1:08 pm

LLY

Morgan Stanley analyst David Phung has maintained an 'Overweight' rating on Eli Lilly (NYSE:LLY) and raised the price target from $507 to $551.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 1:06 pm

CHRS

CMC

NUE

PLTR

RMBS

Jim Cramer, host of CNBC's 'Mad Money Lightning Round', expressed his views on several companies. He endorsed Rambus Inc. (RMBS), despite its slow progress, and remained bullish on Palantir Technologies Inc. (PLTR) following a strong quarter. He also spoke positively about Commercial Metals Company (CMC), ranking it second only to Nucor Corporation (NUE) in the metal recycling business. Lastly, he referred to Coherus BioSciences, Inc. (CHRS) as a 'good spec'.

Portfolio Pulse from Lisa Levin

July 11, 2023 | 1:06 pm

BMY

Morgan Stanley analyst Terence Flynn has reiterated an 'Underweight' rating on Bristol-Myers Squibb (BMY) and maintained a price target of $59.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 1:04 pm